US Stock MarketDetailed Quotes

ZLAB Zai Lab

Watchlist
  • 33.910
  • +0.960+2.91%
Close Feb 25 16:00 ET
  • 33.000
  • -0.910-2.68%
Post 17:39 ET
3.71BMarket Cap-12.11P/E (TTM)

About Zai Lab Company

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Company Profile

SymbolZLAB
Company NameZai Lab
Listing DateSep 20, 2017
Issue Price18.00
Founded2014
CEODr. Samantha Du
MarketNASDAQ
Employees2175
Securities TypeDR
ADS Ratio1.0 : 10.0
Fiscal Year Ends12-31
AddressJinchuang Plaza,Building 1, 4/F,No. 4560 Jinke Road, Pudong District
CityShanghai
ProvinceShanghai
CountryChina
Zip Code201210
Phone86-21-6163-2588

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Samantha Du
  • Chairwoman of the Board and Chief Executive Officer
  • 12.04M
  • Joshua Smiley
  • Chief Operating Officer and President
  • 5.55M
  • Dr. Yajing Chen
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Frazor Titus Edmondson, III
  • Chief Legal Officer
  • --
  • Dr. Rafael G. Amado, M.D.
  • President, Head of Global Oncology Research and Development
  • 4.87M
  • Dr. Kaixian Chen, PhD
  • Independent Director
  • 557.48K
  • Dr. John D. Diekman,PhD
  • Lead Independent Director
  • 608.44K
  • Leon O. Moulder, Jr
  • Independent Director
  • 574.35K
  • Peter Wirth, J.D.
  • Independent Director
  • 576.15K
  • William Lis
  • Independent Director
  • 567.03K
  • Scott W. Morrison
  • Independent Director
  • 570.77K
  • Michel Vounatsos
  • Independent Director
  • 821.25K
  • Nisa Bernice Wing-Yu Leung, J.P.
  • Independent Director
  • --
  • Dr. Richard B. Gaynor, M.D.
  • Independent Director
  • 564.98K

Trending Stocks

Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More